# Filana Therapeutics, Inc.: Form 8-K/A, filed Oct 1, 2024

- Company: [Filana Therapeutics, Inc.](/companies/flna.md) (CIK 1069530)
- Form: 8-K/A
- Filed: 2024-10-01
- Accepted by EDGAR: Oct 1, 2024, 16:07 ET
- Period: 2024-09-06
- Accession: 0001437749-24-030345
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1069530/000143774924030345/sava20240930_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1069530/000143774924030345/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1069530/000143774924030345/sava20240930_8ka.htm

Filed Oct 1, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-030345. Last ingested by Listed: Nov 5, 2026, 16:57 ET. No prices; not investment advice.